Professor, Medicine, University of Vermont College of Medicine
Cardiology
Dr. Harold L. Dauerman, MD
|
|
Give Review
Harold Dauerman works in the field of Cardiology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Harold L. Dauerman, MD is a published doctor. He has 60 papers published. The most current publication "Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's Cat..." Harold Dauerman accepts all Medicare patients.
Publications
- Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry's Cat...
- Thrombotic complications associated with early and late nonadherence to dual antiplatelet therapy.
- Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study.
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- A regional pharmacoinvasive PCI strategy incorporating selected bleeding avoidance strategies.
- Reconsidering the necessity of aspirin in stable Coronary artery disease.
- Reducing contrast-induced Acute kidney injury using a regional multicenter quality improvement intervention.
- Death and Interventional Cardiology: A Tale of Two Trials.
- Rewriting the history of vascular closure devices.
- Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics: optical coherence tomography study.
- Deconstructing the Language of Bleeding.
- Esophageal assessments of left ventricular filling pressures: A proof-of-concept study.
- Antithrombotic treatment in transcatheter Aortic valve implantation: insights for cerebrovascular and bleeding events.
- Coronary Artery Disease: an international disease-oriented journal.
- Antiplatelet therapy in prevention of cardio- and venous thromboembolic events.
- Incidence and Outcomes Associated With Early Heart Failure Pharmacotherapy in Patients With Ongoing Cardiogenic Shock.
- Gender related differences in predictors of vascular complications: role of vessel size and BMI.
- The Softer Side of Bleeding.
- Women, bleeding, and Coronary intervention.
- Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with Acute coronary syndromes: insigh...
- High dose intraCoronary N-acetylcysteine in a porcine model of ST-elevation myocardial infarction.
- Lipid rich plaque, female gender and proximal coronary stent edge Dissections.
- Increased local cytokine production at culprit superficial femoral Artery plaques.
- Bleeding Complications With Regional Adaptation of a Prolonged Bivalirudin Regimen for ST-Elevation Acute Myocardial Infarction.
- Toward a comprehensive approach to pharmacoinvasive therapy for patients with ST segment elevation Acute myocardial infarction.
- Platelet-Mediated Thrombosis and Drug-Eluting Stents.
- The magic of disappearing stents.
- Bleeding avoidance strategies consensus and controversy.
- Reasonable incomplete revascularization.
- Contrast-induced Acute kidney injury.
- Angiographic predictors of vascular complications among women undergoing cardiac catheterization and intervention.
- Bridging the gap between clinical trials of antiplatelet therapies and applications among elderly patients.
- Percutaneous Coronary intervention, diabetes mellitus, and death.
- In search of an algorithm to prevent Acute kidney injury.
- Significantly improved vascular complications among women undergoing percutaneous Coronary intervention: a report from the Northern New England Percutaneous Coronary I...
- Challenges in oral antiplatelet therapy: ST-segment elevation Myocardial infarction.
- Consistent door-to-balloon times of less than 90 minutes for STEMI patients transferred for Primary PCI.
- N-acetylcysteine-enhanced contrast provides cardiorenal protection.
- Coronary intervention without a safety net.
- Extravascular closure for patients with high-risk femoral anatomy.
- Clinical, procedural, and pharmacologic correlates of Acute and subAcute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
- Percutaneous Coronary intervention pharmacology: from a triangle to a square.
- Vascular closure devices: the second decade.
- Complete Cypher stent fracture and migration in the ostium of the right Coronary artery.
- Detection of Coronary artery stenosis using 40-channel computed tomography with multi-segment reconstruction.
- Coronary venous capture of contrast during angiography.
- Treatment of stent restenosis: moving beyond momentum.
- Increased expression of platelet P-selectin and formation of platelet-leukocyte aggregates in blood from patients treated with unfractionated heparin plus eptifibatide...
- Bleeding complications in patients with anemia and Acute myocardial infarction.
- Relation of leukocytosis to C-reactive protein and interleukin-6 among patients undergoing percutaneous Coronary intervention.
- A novel use for a distal embolic protection device: stent retrieval.
- Endothelial dysfunction and inflammation after percutaneous Coronary intervention.
- Increased Coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit Coronary plaques.
- Comparison of inflammatory markers in patients with diabetes mellitus versus those without before and after Coronary arterial stenting.
- Synergistic treatment of ST-segment elevation Myocardial infarction with pharmacoinvasive recanalization.
- The early days after ST-segment elevation Acute myocardial infarction: reconsidering the delayed invasive approach.
- Outcomes of percutaneous Coronary intervention among elderly patients in cardiogenic shock: a multicenter, decade-long experience.
- Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after Coronary arterial stenting.
- Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study.
Schools
Harvard Medical School
Beth Israel Deaconess Med Center
Mass Gen Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Beth Israel Deaconess Medical Center -
Massachusetts General Hospital -
Harvard Medical School
Drug Facts
| NPI NUMBER | 1760494272 | |
| NPPES Provider LastName | DAUERMAN | |
| NPPES Provider FirstName | HAROLD | |
| NPPES Provider ZIPCode | 054011473 | |
| NPPES Provider State | VT | |
| Specialty Description | Cardiology | |
| Total Claim Count | 217.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760494272 |
| Last Name Of The Provider | DAUERMAN |
| First Name Of The Provider | HAROLD |
| View All |
Similar Doctors
|
|
Dr. Guoxiang Chu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Van Buren, MD |
|
|
Dr. Nathaniel C. Thompson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joachim G. Mueller, MD |
|
|
Dr. Edward F. Terrien, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. David J. Coyle, MD |
|
|
Dr. Shahab Moossavi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Friederike K. Keating, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Naveen A. Seecheran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gangadhar R. Malasana, MD |
|
|
Dr. Magdalena A. Zeglin-Sawczuk, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohamad A. Nawar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick K. Hohl, DO
This Doctor is OpenDoctor Recommended.
|